INSULIN-SECRETION, GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AFTER ORAL GLUCOSE IN CIRRHOSIS

被引：0
|
作者：
KRUSZYNSKA, Y
GHATEI, M
BLOOM, S
MCINTYRE, N
机构：
来源：
DIABETES | 1993年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A174 / A174
页数：1
相关论文
共 50 条
  • [1] INSULIN-SECRETION, GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE AFTER ORAL GLUCOSE IN CIRRHOSIS
    KRUSZYNSKA, YT
    GHATEI, M
    BLOOM, SR
    MCINTYRE, N
    HEPATOLOGY, 1993, 18 (04) : A270 - A270
  • [2] EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANTIBODIES ON GLUCOSE-INDUCED INSULIN-SECRETION IN RATS
    SHIMA, K
    OHBOSHI, C
    HIROTA, M
    BIOMEDICAL RESEARCH-TOKYO, 1989, 10 (05): : 417 - 422
  • [3] Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), Gastric Inhibitory Polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections
    Nauck, MA
    Siemsgluss, J
    Orskov, C
    Holst, JJ
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (03): : 159 - 166
  • [4] Glucagon-like peptide-1 (GLP-1) and leptin secretion after an oral glucose load in obese patients.
    Mannucci, E
    Ognibene, A
    Cremasco, F
    Bardini, G
    Mencucci, A
    Ciani, S
    Pierazzuoli, E
    Rotella, CM
    DIABETOLOGIA, 1999, 42 : A195 - A195
  • [5] EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON INSULIN-SECRETION
    SHIMA, K
    HIROTA, M
    OHBOSHI, C
    REGULATORY PEPTIDES, 1988, 22 (03) : 245 - 252
  • [6] HYPERSECRETION OF TRUNCATED GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE IN OBESE PATIENTS
    FUKASE, N
    IGARASHI, M
    TAKAHASHI, H
    MANAKA, H
    YAMATANI, K
    DAIMON, M
    TOMINAGA, M
    SASAKI, H
    DIABETIC MEDICINE, 1993, 10 (01) : 44 - 49
  • [7] HYPERSECRETION OF TRUNCATED GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE IN OBESE PATIENTS
    FUKASE, N
    TAKAHASHI, H
    IGARASHI, M
    MANAKA, H
    YAMATANI, K
    DAIMON, M
    TOMINAGA, M
    SASAKI, H
    REGULATORY PEPTIDES, 1992, 40 (02) : 150 - 150
  • [8] Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
    Bulum, Tomislav
    BIOMEDICINES, 2022, 10 (10)
  • [9] Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits
    Gjesing, A. P.
    Ekstrom, C. T.
    Eiberg, H.
    Urhammer, S. A.
    Holst, J. J.
    Pedersen, O.
    Hansen, T.
    DIABETOLOGIA, 2012, 55 (05) : 1338 - 1345
  • [10] Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits
    A. P. Gjesing
    C. T. Ekstrøm
    H. Eiberg
    S. A. Urhammer
    J. J. Holst
    O. Pedersen
    T. Hansen
    Diabetologia, 2012, 55 : 1338 - 1345
12345